Physician profile

John E Russo

General Practice (Dentist) · Orlando, FL

NPI 1679538367

$7,711.67

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Long Term Medical Supply Or Device Loan$535.32
Food and Beverage$29.40

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Carl Zeiss Meditec USA, INC. $5,559.08 2022-2023 Proergo
Meisinger USA, LLC $1,700.00 2021
Straumann USA LLC $258.36 2022-2024
Biohorizons Implant Systems INC. $92.11 2020-2022
Biolase, INC. $70.87 2021
Carestream Dental, LLC $18.18 2019
Align Technology, INC. $13.07 2023 Invisalign

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John E Russo

$7,711.67

in general payments reported 2019-2025

Years
2019-2024
Top company
Carl Zeiss Meditec USA, INC.

https://glasscript.com/doctor/76086/john-e-russo

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.